BioMarin is a biotechnology company focused on developing medicines for people living with rare genetic conditions. The company’s research approach draws on genetics and molecular biology to identify disease mechanisms and develop therapies, including enzyme replacement treatments and other approaches. Its portfolio includes marketed medicines and clinical and preclinical candidates for rare diseases. BioMarin publishes information about its science, products, clinical studies, and patient support through its official website. Treatment availability and eligibility depend on the specific medicine and jurisdiction and should be confirmed with healthcare professionals.
Claim this company profile
Please sign in to claim this profile.
Company reviews
No approved reviews yet.
Please sign in to write a review. One review per account and company.